| # | Drug | Count |
|---|---|---|
| 0 | OXALIPLATIN | 24 |
| 1 | RITUXIMAB | 23 |
| 2 | ADALIMUMAB | 19 |
| 3 | DOXORUBICIN | 19 |
| 4 | CYCLOPHOSPHAMIDE | 16 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 16 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 16 |
| 7 | TRASTUZUMAB | 15 |
| 8 | FLUOROURACIL | 14 |
| 9 | FLUOROURACIL CREAM, 0.5% | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ONTRUZANT | 8 | 0.0153 |
| 1 | ZOLBETUXIMAB | 3 | 0.0020 |
| 2 | MIGALASTAT HYDROCHLORIDE | 1 | 0.0018 |
| 3 | CEFUROXIME SODIUM | 1 | 0.0008 |
| 4 | LIDOCAINE AND PRILOCAINE | 1 | 0.0007 |
| 5 | EDARAVONE | 1 | 0.0006 |
| 6 | SELUMETINIB | 1 | 0.0006 |
| 7 | MITOMYCIN | 2 | 0.0005 |
| 8 | ADALIMUMAB-AFZB | 1 | 0.0004 |
| 9 | BISMUTH SUBSALICYLATE | 2 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 3 | 0.0020 |
| 1 | Bismuth [EPC] | 2 | 0.0004 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 26 | 0.0003 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 5 | Glinide [EPC] | 2 | 0.0002 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 15 | 0.0002 |
| 7 | Prostacyclin Receptor Agonist [EPC] | 4 | 0.0002 |
| 8 | Allylamine Antifungal [EPC] | 1 | 0.0001 |
| 9 | Microtubule Inhibitor [EPC] | 18 | 0.0001 |